horizon pharma inc
(HZNP:Consolidated Issue Listed on NASDAQ Global Select )
Transactions by HORIZON PHARMA INC (HZNP) in the last 6 months
Horizon Pharma, Inc. (NasdaqGS:HZNP) entered into an agreement to acquire Vidara Therapeutics International Limited for approximately $660 million in cash and stock on March 18, 2014. The shareholders of Vidara will recieve approximately 26% of Horizon Pharma plc and receive $200 million in cash, subject to certain adjustments. After the deal is completed, shareholders of Horizon Pharma, Inc. will hold 74% stake in Horizon Pharma plc and shareholders of Vidara Therapeutics ...
Burke Warren Mackay Serritella
Mayer Brown LLP
Horizon Pharma, Inc. (NasdaqGS:HZNP) entered into a commitment letter of senior secured notes for gross proceeds of $250 million in funding with Deerfield Management Company, L.P. on March 18, 2014. The notes carries a coupon of 12.25% per annum and would mature in five years. The company will pay $5 million to the investor upon the execution of the commitment letter. The company will also reimburse reasonable and documented out of pocket expenses for attorneys, accountants ...
|Depomed Inc||$14.70 USD||-0.05|
|Pfizer Inc||$28.90 USD||+0.01|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|